First Light Asset Management, LLC 13F holdings, Q4 2024
Holdings as of December 31, 2024 · filings on SEC EDGAR · latest filing →
First Light Asset Management, LLC disclosed 36 US equity positions worth $1.0bn in its Q4 2024 13F filing. The largest position was FNAUSD at 10.5% of the reported book, followed by CNTA and AXGN. Against the Q3 2024 filing, it opened 9 new positions, added to 9 and reduced 18 among the top 36 holdings.
What did First Light Asset Management, LLC own in Q4 2024? Top 36 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2024 |
|---|---|---|---|---|---|---|---|
| 1 | FNAUSD PARAGON 28 INC | 10.5% | $109.3m | 10,580,467 | 4% | added | |
| 2 | CNTA CENTESSA PHARMACEUTICALS LIMITED | 9.3% | $97.2m | 5,805,184 | -2% | reduced | |
| 3 | AXGN AXOGEN INC | Healthcare | 7.1% | $74.3m | 4,506,795 | 10% | added |
| 4 | ATRC ATRICURE INC | Healthcare | 5.8% | $60.2m | 1,969,221 | 6% | added |
| 5 | TWST TWIST BIOSCIENCE CORPORATION | Healthcare | 5.5% | $57.0m | 1,226,255 | – | new |
| 6 | VERA VERA THERAPEUTICS INC | Healthcare | 5.1% | $53.3m | 1,261,246 | 79% | added |
| 7 | NEO NEOGENOMICS INC | Healthcare | 5.0% | $52.2m | 3,167,585 | 3% | added |
| 8 | XENE XENON PHARMACEUTICALS | Healthcare | 4.4% | $45.5m | 1,160,580 | -2% | reduced |
| 9 | CRNXGBP CRINETICS PHARMACEUTICALS INC | 4.3% | $45.3m | 885,453 | -6% | reduced | |
| 10 | IRTC IRHYTHM TECHNOLOGIES | Healthcare | 3.7% | $38.8m | 430,500 | – | new |
| 11 | HCAT HEALTH CATALYST INC | Healthcare | 3.5% | $37.1m | 5,241,121 | 22% | added |
| 12 | PFMTUSD PERFORMANT HEALTHCARE, INC. | 3.3% | $34.3m | 11,346,649 | 1% | added | |
| 13 | INSM INSMED INC | Healthcare | 3.1% | $32.5m | 470,192 | -32% | reduced |
| 14 | MDXG MIMEDX GROUP INC | Healthcare | 3.1% | $32.2m | 3,343,861 | – | new |
| 15 | RARE ULTRAGENYX PHARMACEUTICAL INC | Healthcare | 3.1% | $32.1m | 763,607 | 1% | added |
| 16 | KRMD KORU MEDICAL SYSTEMS INC | 2.2% | $22.8m | 5,915,434 | 6% | added | |
| 17 | PLRX PLIANT THERAPEUTICS INC | Healthcare | 2.1% | $22.1m | 1,681,110 | -35% | reduced |
| 18 | EWTX EDGEWISE THERAPEUTICS INC | 2.0% | $20.8m | 780,639 | – | new | |
| 19 | JANX JANUX THERAPEUTICS INC | Healthcare | 1.6% | $16.8m | 313,782 | – | new |
| 20 | SIBN SI-BONE INC | Healthcare | 1.5% | $15.9m | 1,136,982 | -26% | reduced |
| 21 | KYMR KYMERA THERAPEUTICS INC | Healthcare | 1.5% | $15.4m | 383,310 | -6% | reduced |
| 22 | NTRA NATERA INC | Healthcare | 1.4% | $14.7m | 93,088 | -50% | reduced |
| 23 | BFLY BUTTERFLY NETWORK INC | 1.2% | $12.5m | 3,994,620 | – | new | |
| 24 | RGEN REPLIGEN CORP | Healthcare | 1.1% | $11.9m | 82,455 | -50% | reduced |
| 25 | ANAB ANAPTYS BIO INC | Healthcare | 1.1% | $11.5m | 868,882 | -8% | reduced |
| 26 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 1.0% | $10.8m | 398,855 | -21% | reduced |
| 27 | TNDM TANDEM DIABETES CARE INC | Healthcare | 1.0% | $10.5m | 292,117 | -72% | reduced |
| 28 | DYN DYNE THERAPEUTICS INC | Healthcare | 0.9% | $9.9m | 420,431 | -67% | reduced |
| 29 | ELDN ELEDON PHARMACEUTICALS INC | 0.9% | $9.6m | 2,328,768 | – | new | |
| 30 | GH GUARDANT HEALTH | Healthcare | 0.9% | $9.5m | 309,389 | -52% | reduced |
| 31 | PODD INSULET CORP | Healthcare | 0.8% | $8.8m | 33,821 | -79% | reduced |
| 32 | TMDX TRANSMEDICS GROUP INC | Healthcare | 0.8% | $8.7m | 139,757 | -47% | reduced |
| 33 | OSCR OSCAR HEALTH INC CLASS A | Healthcare | 0.7% | $7.3m | 546,822 | -69% | reduced |
| 34 | SENS SENSEONICS HOLDINGS INC | Healthcare | 0.3% | $3.4m | 6,431,799 | – | new |
| 35 | EVH EVOLENT HEALTH INC | Healthcare | 0.1% | $603.2k | 53,620 | -98% | reduced |
| 36 | IWO ISHARES RUSSELL 2000 GROWTH ETF | 0.0% | $347.7k | 1,208 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.